Explore how control and data buses enable seamless transmission and timely, synchronised imaging for high-performance ...

Southern Cross Gold Consolidated Ltd (TSX: SXGC) (ASX: SX2) (OTC Pink: MWSNF) (FSE: MV3) ("SXGC", "SX2" or the "Company") is ...

Bulk open pit potential emerging at Icon / Apollo Trend HIGHLIGHTS:New step-out holes drilled at Icon targeting a large gap ...

AstraZeneca’s top-selling drug Tagrisso is already widely used on its own as a first-line treatment for EGFR-mutated lung cancer, but new data suggests there can be benefits from combining it ...

Takeda has reported updated results from its ALTA-1L trial of Alunbrig (brigatinib) versus Xalkori (crizotinib) in first-line treatment of AK-positive non-small cell lung cancer (NSCLC), saying ...